Editor's note: Seeking Alpha is proud to welcome Stephan Otzen as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more »
AcelRx Pharmaceuticals (ACRX) offers opioid based medication for acute moderate-to-severe pain. Its stock price has declined significantly over the last 6 months, but I believe there is limited further downside from a fundamental perspective, coupled with extreme upside over the next 12 months and going forward.